This week: psychedelic stocks took a nosedive on Tuesday, and Novamind secures insurance coverage for ketamine from four major providers.
Welcome to This Week in Psychedelics! Find out which US city just approved a ballot initiative to decriminalize psychedelics.
Activists press Oakland, CA to allow local producers to sell ethnogenic substances, UK Prime Minister Boris Johnson to consider reclassifying psilocybin
Pennsylvania, Denver and Detroit consider psilocybin decriminalization and/or therapy
New research indicates psychedelics can reduce opioid use by 55%. And microdosing is in the spotlight of a new study by MindMed.
Genentech's multiple sclerosis treatment shows major promise; atai Beckley to meet with the FDA about its new depression treatment.
.png){kind=small}
